Brief: Monopar Initiates Early-Stage Trial For MNPR-101-Zr In Advanced Cancer Patients
10/04/2024 13:19
April 10 (Reuters) - Monopar Therapeutics Inc MNPR.O :
* MONOPAR INITIATES RADIOPHARMA PHASE 1 CLINICAL TRIAL FOR
MNPR-101-ZR IN ADVANCED CANCER PATIENTS
* MONOPAR THERAPEUTICS INC: PHASE 1 DOSIMETRY TRIAL IS
EVALUATING
SAFETY AND DOSIMETRY OF MNPR-101-ZR IN UP TO 12 PATIENTS WITH
ADVANCED CANCER
Source text for Eikon: ID:nGNXbYDjxK
Further company coverage: MNPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Monopar Therapeutics
See all newsBrief: Monopar Appoints Jeffrey D. Kent, M.D., As Executive Vice President, Head Of Medical Affairs Announces Two Alxn1840 Presentations At Aasld – The Liver Meeting 2026
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Monopar Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Monopar Therapeutics Inc. expected to post a loss of 62 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Alphabet, IBM, Tesla